The evaluation of some biochemical parameters in pyridoxine-treated calcium oxalate renal stone formers
- PMID: 929778
- DOI: 10.1159/000280150
The evaluation of some biochemical parameters in pyridoxine-treated calcium oxalate renal stone formers
Abstract
Several serum and urinary constitutents were evaluated in 13 calcium oxalate kidney stone formers in whom according to urinary vitamin B6 excretion sufficient vitamin B6 intake before the study was suggested. The influence of 28-day Pyridoxine (Spofa) supplementation (20 mg three times daily) on these biochemical parameters was searched. Pyridoxine supplementation was followed by a significant increment in the mean values of serum uric acid; the remaining serum constitutents did not change. Urinary calcium, phosphare, magnesium, sodium, potassium, and uric acid slightly increased, urinary oxalate excretion slightly fell; there was a high variability in the changes between the individuals. No changes in the mean values of clearance of endogenous creatinine, percentage of tubular reabsorption of phosphate and urinary zinc excretion were found. It is suggested that long-term studies are necessary to search the factors influencing successful stone prevention or stone recurrency in pyridoxine-treatment patients.
Similar articles
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
-
[Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].Hinyokika Kiyo. 1987 Sep;33(9):1321-30. Hinyokika Kiyo. 1987. PMID: 3434487 Japanese.
-
Effect of combined supplementation of magnesium oxide and pyridoxine in calcium-oxalate stone formers.Urol Res. 1994;22(3):161-5. doi: 10.1007/BF00571844. Urol Res. 1994. PMID: 7992461
-
[Clinical studies of the recurrence of urolithiasis (3). Influence of sodium intake on urinary excretion of calcium, uric acid, oxalate, phosphate and magnesium].Hinyokika Kiyo. 1988 Sep;34(9):1537-41. Hinyokika Kiyo. 1988. PMID: 3213789 Japanese.
-
Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.Scand J Urol Nephrol Suppl. 1989;119:1-53. Scand J Urol Nephrol Suppl. 1989. PMID: 2669121 Review.
Cited by
-
Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.Int Urol Nephrol. 1988;20(4):353-9. doi: 10.1007/BF02549567. Int Urol Nephrol. 1988. PMID: 3170105
-
Vitamins as regulators of calcium-containing kidney stones - new perspectives on the role of the gut microbiome.Nat Rev Urol. 2023 Oct;20(10):615-637. doi: 10.1038/s41585-023-00768-5. Epub 2023 May 9. Nat Rev Urol. 2023. PMID: 37161031 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources